Dalian Thermal Power Co.,Ltd. (600719.SS)
CNY 7.69
(-5.64%)
CNY 7.69
(-5.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -68.63 Million | 332.63 Million | 64.62 Million | 154.71 Million | 216.3 Million | -86.12 Million |
| Net Income | 105.56 Million | -156.54 Million | -143.21 Million | 9.65 Million | 11.27 Million | 2.7 Million |
| Depreciation & Amortization | 119.2 Million | 100.27 Million | 93.1 Million | 89.75 Million | 63.59 Million | 62.61 Million |
| Deferred income taxes | 14.42 Million | 859.95 Thousand | 1.47 Million | 1.08 Million | -2.04 Million | 57.57 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -60.54 Million | 329.4 Million | 37.82 Million | 13.4 Million | 104.37 Million | -167.02 Million |
| Other non-cash items | 51.65 Million | 59.49 Million | 76.91 Million | 41.88 Million | 37.05 Million | 15.58 Million |
| Investing Cash Flow | -25.16 Million | -334.22 Million | -276.78 Million | -220.04 Million | -288.66 Million | -269.3 Million |
| Investments in PPE | -225.16 Million | -367.54 Million | -276.78 Million | -220.66 Million | -288.66 Million | -269.3 Million |
| Acquisitions | 200 Million | 33.31 Million | - | 621.8 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 200 Million | 0.15 | - | -220.66 Million | -288.66 Million | -269.3 Million |
| Financing Cash Flow | 29.28 Million | -241.03 Million | 11.85 Million | 411.66 Million | 179.21 Million | 355.55 Million |
| Debt repayment | -103.92 Million | -974.1 Million | -704.5 Million | -791.3 Million | -760.2 Million | -300.27 Million |
| Dividends payments | -84.46 Million | -83.94 Million | -3.23 Million | -3.64 Million | -2.02 Million | -24.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 217.67 Million | 817 Million | 796.59 Million | 1.25 Billion | 979.99 Million | 679.99 Million |
| Accounts receivables | 56.32 Million | 115.11 Million | -42.32 Million | 57.8 Million | -24.94 Million | -93.26 Million |
| Accounts payables | -86.15 Million | 81.53 Million | 184.18 Million | 5.19 Million | 131.52 Million | -60.71 Million |
| Inventory | -30.71 Million | 131.9 Million | -105.51 Million | -50.68 Million | -153.49 Thousand | -13.1 Million |
| Other working capital | -71.73 Million | 859.95 Thousand | 1.47 Million | 1.08 Million | -2.04 Million | -153.92 Million |
| Cash at beginning of period | 159.06 Million | 321.77 Million | 522.07 Million | 175.73 Million | 68.88 Million | 68.76 Million |
| Cash at end of period | 83.98 Million | 79.13 Million | 321.77 Million | 522.07 Million | 175.73 Million | 68.88 Million |
| Capital Expenditure | -225.16 Million | -367.54 Million | -276.78 Million | -220.66 Million | -288.66 Million | -269.3 Million |
| Effect of forex changes on cash | -10.56 Million | - | 1.74 | - | - | - |
| Net cash flow / Change in cash | -75.07 Million | -242.63 Million | -200.3 Million | 346.34 Million | 106.84 Million | 123.44 Thousand |
| Free Cash Flow | -293.79 Million | -34.91 Million | -212.15 Million | -65.95 Million | -72.36 Million | -355.42 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -75.02 Million | -66.62 Million | 25.26 Million | -33.05 Million | 105.56 Million | -68.38 Million |
| Depreciation & Amortization | - | 33.66 Million | 33.66 Million | 29.4 Million | 119.2 Million | -60.41 Million |
| Deferred income taxes | - | - | - | - | 14.42 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 157.64 Million | - | 25.61 Million | -60.54 Million | -316.3 Million |
| Other non-cash items | -66.05 Million | 33 Million | -82.06 Million | 212.04 Million | 51.65 Million | 358.3 Million |
| Investing Cash Flow | -5.74 Million | -30.7 Million | -24.79 Million | -50.39 Million | -25.16 Million | 186.75 Million |
| Investments in PPE | -5.74 Million | -30.7 Million | -24.79 Million | -50.39 Million | -225.16 Million | -13.24 Million |
| Acquisitions | - | - | - | - | 200 Million | 200 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 200 Million | -0.90 |
| Financing Cash Flow | 116.91 Million | 79.33 Million | 124.53 Million | -206.9 Million | 29.28 Million | -78.49 Million |
| Debt repayment | -60 Million | -140 Thousand | -146.66 Million | -117.8 Million | -103.92 Million | -155 Million |
| Dividends payments | -23.08 Million | -20.44 Million | -22.12 Million | -19.31 Million | -84.46 Million | -23.49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 200 Million | 79.47 Million | -22.12 Million | -69.78 Million | 217.67 Million | 100 Million |
| Accounts receivables | - | 57.77 Million | - | 56.32 Million | 56.32 Million | -350.88 Million |
| Accounts payables | - | - | - | - | -86.15 Million | - |
| Inventory | - | 99.87 Million | - | -30.71 Million | -30.71 Million | 34.57 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 38.9 Million | 226.92 Million | 83.98 Million | 37.9 Million | 159.06 Million | 16.44 Million |
| Cash at end of period | 8.99 Million | 138.9 Million | 226.92 Million | 83.98 Million | 83.98 Million | 37.9 Million |
| Capital Expenditure | -5.74 Million | -30.7 Million | -24.79 Million | -50.39 Million | -225.16 Million | -13.24 Million |
| Effect of forex changes on cash | - | - | - | 69.36 Million | -10.56 Million | -0.58 |
| Net cash flow / Change in cash | -29.9 Million | -88.02 Million | 142.93 Million | 46.07 Million | -75.07 Million | 21.46 Million |
| Free Cash Flow | -146.82 Million | -97.99 Million | -81.59 Million | 183.61 Million | -293.79 Million | -100.04 Million |
300471
HTOO
RRU
7235
VET
NEDAP